NanoString Technologies, Inc. (NASDAQ:NSTG) Shares Acquired by Wrapmanager Inc.

Wrapmanager Inc. lifted its position in shares of NanoString Technologies, Inc. (NASDAQ:NSTGGet Rating) by 52.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,980 shares of the biotechnology company’s stock after buying an additional 3,779 shares during the period. Wrapmanager Inc.’s holdings in NanoString Technologies were worth $382,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Allspring Global Investments Holdings LLC acquired a new stake in NanoString Technologies in the 4th quarter valued at approximately $602,000. BNP Paribas Arbitrage SA increased its holdings in NanoString Technologies by 18.0% in the 4th quarter. BNP Paribas Arbitrage SA now owns 9,664 shares of the biotechnology company’s stock valued at $408,000 after purchasing an additional 1,477 shares during the last quarter. DekaBank Deutsche Girozentrale increased its holdings in NanoString Technologies by 10.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 14,350 shares of the biotechnology company’s stock valued at $490,000 after purchasing an additional 1,300 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in NanoString Technologies by 2.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 323,393 shares of the biotechnology company’s stock valued at $13,657,000 after purchasing an additional 6,414 shares during the last quarter. Finally, Fisher Asset Management LLC increased its holdings in NanoString Technologies by 1.7% in the 1st quarter. Fisher Asset Management LLC now owns 293,095 shares of the biotechnology company’s stock valued at $10,185,000 after purchasing an additional 4,859 shares during the last quarter.

Analyst Upgrades and Downgrades

NSTG has been the subject of several research reports. Morgan Stanley dropped their target price on shares of NanoString Technologies from $30.00 to $28.00 and set an “equal weight” rating for the company in a report on Monday, August 8th. Robert W. Baird decreased their price target on shares of NanoString Technologies from $30.00 to $21.00 in a research report on Friday, August 5th. Finally, Cowen decreased their price target on shares of NanoString Technologies to $31.00 in a research report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $39.14.

NanoString Technologies Stock Performance

Shares of NSTG stock opened at $15.51 on Wednesday. The company has a quick ratio of 6.04, a current ratio of 6.84 and a debt-to-equity ratio of 2.00. NanoString Technologies, Inc. has a 52 week low of $11.12 and a 52 week high of $62.34. The stock has a market capitalization of $721.06 million, a PE ratio of -5.10 and a beta of 1.92. The firm has a 50 day moving average of $13.67 and a two-hundred day moving average of $22.39.

NanoString Technologies (NASDAQ:NSTGGet Rating) last released its quarterly earnings data on Thursday, August 4th. The biotechnology company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by ($0.23). The firm had revenue of $32.22 million for the quarter, compared to analysts’ expectations of $32.32 million. NanoString Technologies had a negative return on equity of 87.86% and a negative net margin of 97.45%. NanoString Technologies’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the firm posted ($0.60) earnings per share. On average, research analysts predict that NanoString Technologies, Inc. will post -2.55 EPS for the current fiscal year.

NanoString Technologies Company Profile

(Get Rating)

NanoString Technologies, Inc develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.

See Also

Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies, Inc. (NASDAQ:NSTGGet Rating).

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.